Skip to main content
S 2057 115th Congress Senate Government Operations and Politics

Pharmaceutical Regulation Conflict of Interest Act

Introduced: November 1, 2017 Introduced by: Baldwin, Tammy Democratic · Wisconsin See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Nov 1, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Pharmaceutical Regulation Conflict of Interest Act

This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration.

The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment.

The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.

What's happening now November 1, 2017

Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 4
D
Whitehouse, Sheldon
Rhode Island · Nov 16, 2017
 D
Hassan, Margaret Wood
New Hampshire · Nov 1, 2017
 D
Markey, Edward J.
Massachusetts · Nov 1, 2017
 D
Shaheen, Jeanne
New Hampshire · Nov 1, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2057: Pharmaceutical Regulation Conflict of Interest Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2057/
MLA
"S. 2057: Pharmaceutical Regulation Conflict of Interest Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2057/.
Bluebook (legal)
S. 2057, 115th Cong. (2026), https://openamerica.io/bill/115-S-2057/.
Markdown link
[S. 2057: Pharmaceutical Regulation Conflict of Interest Act](https://openamerica.io/bill/115-S-2057/)
Report a problem